Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.

Aging doesn’t only take a toll on the skin. While wrinkles and fine lines are the most noticeable signs of old age, there’s ...

As Ghana joins the global community on Friday May 23rd to mark the annual International Day to End Obstetric Fistula (IDEOF), ...

Don't let urinary incontinence prevent you from the daily activities that you enjoy. Contact your doctor to find out what treatment will work best for you.

Recently reported results from an open-label extension trial show positive safety and efficacy results after 52 weeks of use ...

Patients and clinicians have welcomed the results of the ACT4 PLATO trial, which was the first clinical trial in the world to ...

From headaches and fatigue to hair loss and sleep troubles, the symptoms marking the transition to menopause can overlap with ...

Discover a study that compared two treatment methods for overactive bladder in patients with multiple sclerosis. Learn more.

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...